✨ Free AI Report
Terumo Corporation: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Terumo Corporation
Company Research

Terumo Corporation: Business Overview, Financials & Competitive Analysis

Terumo Corporation scores 7/10 on the AskCyborg Cyborg Score (Solid). Established global medical device leader with proven innovation capability and favorable demographic tailwinds, trading on solid fundamentals with modest growth prospects. Terumo demonstrates strong fundamentals with diversified medical device portfolio, consistent revenue growth, and strategic positioning in high-demand markets. However, pricing pressures and competitive consolidation in the industry present ongoing.

What is Terumo Corporation's industry? Terumo Corporation (terumo.com) operates in Medical Devices & Healthcare Technology. AskCyborg classifies Terumo Corporation under Medical Devices & Healthcare Technology in its company registry.

Terumo is a global leader in medical technology with over 100 years of heritage in healthcare innovation. The company produces prefilled syringes, insulin patch pumps, neurovascular and cardiac vascular interventional...

7/ 10Solid

Cyborg Score thesis

Established global medical device leader with proven innovation capability and favorable demographic tailwinds, trading on solid...

Read the full analyst-debate transcript →
Industry Medical Devices & Healthcare Technology
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: November 2, 2026
AI-Generated Research
30+ Page Report

Get the Latest Terumo Corporation Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Terumo Corporation

AskCyborg analysts argue the bull and bear cases for Terumo Corporation across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Terumo Corporation OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Terumo Corporation Overview

Pro stress-test →

Terumo is a global leader in medical technology with over 100 years of heritage in healthcare innovation. The company produces prefilled syringes, insulin patch pumps, neurovascular and cardiac vascular interventional devices, and blood processing systems, with cardiac and vascular business contributing over 60% of total revenue. North America represents 38% of Terumo's revenue, establishing it as a truly global player.

Strategic Profile

Pro stress-test →

Strong product innovation, market share gains, and demographic trends position the company for sustained expansion, while operational improvements and strategic R&D investments support long-term margin growth. Growing demand in major markets and effective pricing increases in cardiovascular segments, combined with expansion in China and high-margin consumables, are boosting profitability and cash flow.

Competitive Landscape

Pro stress-test →

Primary competitors include Boston Scientific, Medtronic, and Merit Medical Systems, alongside regional players like Japan Lifeline and Asahi Intecc. Terumo competes through product innovation, manufacturing excellence, and market share gains in high-margin therapeutic segments.

Industry Context

Terumo Corporation operates in Medical Devices & Healthcare Technology.

Key facts

Founded: 1921 · Headquarters: Tokyo, Japan · Employees: 30,000+ · Revenue: 1.04 trillion JPY (2024)

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Terumo Corporation.

  • Cardiac and vascular segment dominates at 60%+ of revenue, providing focused competitive advantage in high-growth interventional markets
  • North America-heavy revenue concentration (38%) provides stability but geographic diversification remains a growth opportunity
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • March 2024Terumo Blood and Cell Technologies partners with CiRA Foundation for automated iPS cell manufacturing
  • February 2024International consensus recommendations published for pregnancy complications in sickle cell disease patients
  • +1 moreTrack every material event for Terumo Corporation as it happens. Explore monitoring →
Get alerted when Terumo Corporation has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

MedtronicDiversified medical device and healthcare solutions→Boston ScientificVascular and interventional medical devices→Merit Medical SystemsSpecialty medical devices→

Compare Terumo Corporation with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Terumo Corporation operates in Medical Devices & Healthcare Technology. See how the rest of the sector scores on the Cyborg framework.

Browse Medical Devices & Healthcare Technology research →
NEW · MCP server

Ask your AI assistant about Terumo Corporation

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Terumo Corporation and its top competitor on Cyborg Score”
“What did Terumo Corporation do this quarter?”
“Is Terumo Corporation a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com (you must copy support@askcyborg.com) · Terms of Service

Frequently asked questions

What does Terumo Corporation do?+
Terumo is a global leader in medical technology with over 100 years of heritage in healthcare innovation. The company produces prefilled syringes, insulin patch pumps, neurovascular and cardiac vascular interventional...
What is Terumo Corporation's Cyborg Score?+
Terumo Corporation has a Cyborg Score of 7/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Terumo Corporation's main competitors?+
Named competitors include Medtronic, Boston Scientific, Merit Medical Systems. The full competitive landscape is in the AskCyborg report.
How can I get the full Terumo Corporation research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Terumo Corporation research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Terumo Corporation over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Medical Devices & Healthcare Technology research

Companies in the same sector and named competitors, ranked by Cyborg Score.

8Medtronic plc7Koninklijke Philips N.V.7Smith & Nephew plc7Terumo Corporation